Imperial Brands Expects Net Revenue Growth in Low Single Digits

Apr.14.2023
Imperial Brands Expects Net Revenue Growth in Low Single Digits
Tobacco and e-cigarette manufacturer Imperial Brands expects low net revenue growth and increased profit within three years.

On April 13th, tobacco and e-cigarette manufacturer Imperial Brands announced that it is steadily working towards meeting its full-year expectations and anticipates achieving low single-digit net revenue growth. Over the next three years, the company expects its operating profit growth to accelerate, reaching a median compound annual growth rate.


The announcement highlights its main core features in five key points.


The company maintained a strong market share and stable tobacco pricing in five major combustible tobacco markets. The launch of new products such as e-cigarettes, heated tobacco, and modern oral products also contributed to the growth of net income. Despite the impact of COVID-19, the group's adjusted operating profit in the first half of the year remained unchanged from the same period last year, reflecting the effects of COVID-19 on cigarette sales, increased investment in new products, and the impact of exiting the Russian market last year. The company is expected to achieve revenue and profit growth in line with expectations and guidance for the full year. They have completed £523 million of their £1 billion share buyback program for the fiscal year 2023, which represents approximately 2.7% of the issued share capital.


Combustible tobacco market.


Imperial Tobacco is predicting that their market share in the five major markets will remain steady or increase compared to the same period last year in the first half of this year. Although their market share in Germany and the UK is expected to decline, the market share in the US, Spain, and Australia is expected to remain stable or grow, offsetting the decline in those two countries. The company has maintained a strict pricing system in these five major markets.


New tobacco market.


Imperial Tobacco has made progress in the development and launch of new tobacco products. In the e-cigarette market, they have introduced the blu 2.0 product in the UK, Spain, France, Czech Republic, and Portugal.


Due to the strong growth in Europe, it is expected that revenue from new tobacco products will exceed that of the same period last year in the first half of the year. This is enough to offset the decline caused by the uncertainty from the US marketing ban.


Central and Eastern Europe have been integrated into the AAA region, creating the AAACE region.


Imperial Tobacco is transferring the management of its Central and Eastern Europe (CEE) cluster from Europe to the African, Asian, and Australian (AAA) region. The AAA region will now be referred to as AAACE.


The markets that have been affected by the transfer of regional management this time include Poland, the Czech Republic, Ukraine, Slovakia, Hungary, Azerbaijan, Armenia, Georgia, Moldova, Croatia, and Slovenia.


In the half-year restatement report ending on March 31, 2023, Imperial Tobacco reported a total revenue of £1.37 billion in the New Europe region and £965 million in the AAACE region.


The primary source of revenue for the new tobacco industry is Europe. The revenue generated by the new tobacco industry in the New Europe region is worth £74 million, while the Old Europe region generates £77 million worth of revenue. The new tobacco industry in Europe accounts for 5.4% of total revenue.


Note: The original amount of 1.569 billion pounds for Europe minus 199 million pounds for the Central and Eastern European (CEE) region equals the new amount of 1.37 billion pounds for the expanded European region.


The total amount of 965 million pounds was obtained by combining 766 million pounds from the AAA region and 199 million pounds from the CEE region in the AAACE region.


Imperial Brands PLC has published a report according to an announcement made by the company.


The mid-year performance report covering the period ending March 31, 2023, will be released to the public on May 16, 2023.


Reference:


Imperial Brands is expected to meet full-year guidance based on the pre-close trading update.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
According to Law360 on August 31, 2026, a federal judge in North Carolina ruled that a patent sublicense between R.J. Reynolds Vapor Co. and Juul Labs Inc. relieves Reynolds of its obligation to continue paying royalties to Altria Client Services LLC over Vuse Alto. A jury had previously found that Vuse Alto infringed three Altria patents and awarded approximately $95.2 million in past damages, after which Reynolds was ordered to pay an ongoing royalty equal to 5.25% of positive net sales. The new ruling finds that a valid sublicense can eliminate future infringement, potentially ending what Altria described as hundreds of millions of dollars in future royalties.
Sep.01
Spain Plans to Extend Smoking Ban to Terraces and Beaches, Bringing Vapes Under New Restrictions
Spain Plans to Extend Smoking Ban to Terraces and Beaches, Bringing Vapes Under New Restrictions
Spain is advancing a new tobacco-control reform that would expand smoking restrictions to additional public spaces, including restaurant terraces and beaches, while bringing vaping and other nicotine products into the same regulatory framework. The proposed measures aim to reduce secondhand smoke exposure, protect young people and expand smoke-free environments. The proposal remains under legislative development, and final implementation details have not yet been confirmed.
Jul.23
Product | BAT Launches glo Hyper pro+ in Japan, Upgrading the Hyper Platform With Faster Start and Smart Device Management
Product | BAT Launches glo Hyper pro+ in Japan, Upgrading the Hyper Platform With Faster Start and Smart Device Management
British American Tobacco Japan (BAT Japan) has introduced glo Hyper pro+, an upgraded device within the existing glo Hyper platform. The device adds QuickStart™ rapid heating technology, an EasyView™ display and maintenance notification features to improve daily usability. Launched in Japan on July 13, 2026, glo Hyper pro+ maintains compatibility with existing Hyper-format tobacco sticks, including neo, Lucky Strike and KENT.
Jul.30
Ohio Supreme Court Weighs Whether State Consumer Law Can Restrict Flavored Vape Sales
Ohio Supreme Court Weighs Whether State Consumer Law Can Restrict Flavored Vape Sales
The Ohio Supreme Court is hearing a case involving flavored vape sales and whether state authorities can use consumer protection laws to take action against retailers selling unauthorized vape products. Ohio officials argue that selling unauthorized flavored vapes may constitute consumer deception, while retailers argue that tobacco product regulation falls under federal Food and Drug Administration (FDA) authority and that states cannot impose additional restrictions through consumer laws. The case could affect the scope of state-level vape regulation across the United States.
Aug.06
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.
Regulations
Jul.27